Cn|En

现货抗体产品库

Cleaved-COL1A2 (G1102) Rabbit Polyclonal Antibody

产品详情 相关文献 产品问答 相关产品

产品基本信息

产品货号
BD-PC0049
产品名称
Cleaved-COL1A2 (G1102) Rabbit Polyclonal Antibody
别名
COL1A2; Collagen alpha-2(I) chain; Alpha-2 type I collagen
类别
常规抗体
基因名称
COL1A2
蛋白名称
Collagen alpha-2(I) chain
推荐应用
WB
反应种属
Human,Rat,Mouse
浓度
1 mg/ml
存储缓冲液
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% New type preservative N.
Human Gene ID
1278
Human Gene Link
http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&term=1278
Human Swissprot No.
P08123
Human Swissprot Link
http://www.uniprot.org/uniprotkb/P08123/entry
Mouse Swissprot No.
Q01149
Mouse Swissprot Link
http://www.uniprot.org/uniprot/Q01149
免疫原
The antiserum was produced against synthesized peptide derived from human Collagen I alpha2. AA range:1053-1102
特异性
Cleaved-COL1A2 (G1102) Polyclonal Antibody detects endogenous levels of fragment of activated COL1A2 protein resulting from cleavage adjacent to G1102.
稀释度
WB 1:500 - 1:2000. ELISA: 1:10000. Not yet tested in other applications.
预测分子量
92kD
运输及保存条件
-20°C/1 year
宿主
Polyclonal, Rabbit,IgG
背景介绍
This gene encodes the pro-alpha2 chain of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIB, recessive Ehlers-Danlos syndrome Classical type, idiopathic osteoporosis, and atypical Marfan syndrome. Symptoms associated with mutations in this gene, however, tend to be less severe than mutations in the gene for the alpha1 chain of type I collagen (COL1A1) reflecting the different role of alpha2 chains in matrix integrity. Three transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish, Feb 2008],
组织表达
Forms the fibrils of tendon, ligaments and bones. In bones the fibrils are mineralized with calcium hydroxyapatite.
细胞定位
Secreted, extracellular space, extracellular matrix .
信号通路
Focal adhesion;ECM-receptor interaction;
功能
disease:A chromosomal rearrangement involving COL1A2 may be a cause of lipoblastomas, which are benign tumors resulting from transformation of adipocytes, usually diagnosed in children. Translocation t(7;8)(p22;q13) with PLAG1.,disease:Defects in COL1A2 are a cause of osteogenesis imperfecta type I (OI-I) [MIM:166200]. OI-I is a dominantly inherited serious newborn disease characterized by bone fragility, normal stature, little or no deformity, blue sclerae and hearing loss in 50% of families. Dentinogenesis imperfecta is rare and may distinguish a subset of OI type I (formation of dentine).,disease:Defects in COL1A2 are a cause of osteogenesis imperfecta type II (OI-II) [MIM:166210]; also known as osteogenesis imperfecta congenita (OIC) or lethal perinatal. OI-II is a serious newborn disease that diffusely affects bone. Infants are born with multiple fractures, which lead to shortening of the extremities. The skull is soft, and resembles a "bag of bones" when palpated, the sclera are abnormally thin and may appear blue, and some infants also have a hearing loss. Infants born alive often die suddenly during the first few days or weeks of life, but a few survive as deformed dwarfs. Mental development is normal unless head trauma with CNS injury occurs. There is no effective treatment.,disease:Defects in COL1A2 are a cause of osteogenesis imperfecta type III (OI-III) [MIM:259420]. OI-III usually presents with moderate deformity at birth, progressively deforming bones, and sclerae variable in color. Dentinogenesis imperfecta and hearing loss are common. Stature is very short.,disease:Defects in COL1A2 are a cause of osteogenesis imperfecta type IV (OI-IV) [MIM:166220]; also known as osteogenesis imperfecta with normal sclerae. OI-IV presents with moderate to mild deformity and variable short stature. Dentinogenesis imperfecta is common and hearing loss occurs in some.,disease:Defects in COL1A2 are the cause of cardiac valvular form of autosomal recessive Ehlers-Danlos syndrome (cardiac valvular EDS) [MIM:225320]; also known as arthrochalasis type Ehlers-Danlos syndrome. In addition to joint laxity, skin hyperextensibility and friability, and abnormal scar formation, individuals with this form of EDS appear to be at increased risk for cardiac valvular dysfunction.,disease:Defects in COL1A2 are the cause of Ehlers-Danlos syndrome type 7B (EDS7B) [MIM:130060]. EDS is a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDS7B is marked by bilateral congenital hip dislocation, hyperlaxity of the joints, and recurrent partial dislocations.,function:Type I collagen is a member of group I collagen (fibrillar forming collagen).,online information:Collagen type I alpha-2 chain mutations,PTM:Prolines at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains.,similarity:Belongs to the fibrillar collagen family.,subunit:Trimers of one alpha 2(I) and two alpha 1(I) chains.,tissue specificity:Forms the fibrils of tendon, ligaments and bones. In bones the fibrils are mineralized with calcium hydroxyapatite.,
期货
现货
纯化
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Western blot analysis of lysates from Jurkat cells, treated with etoposide 25uM 24h, using Collagen I alpha2 (Cleaved-Gly1102) Antibody. The lane on the right is blocked with the synthesized peptide.

Western Blot analysis of various cells using Cleaved-COL1A2 (G1102) Polyclonal Antibody diluted at 1:1000

Western Blot analysis of VEC cells using Cleaved-COL1A2 (G1102) Polyclonal Antibody diluted at 1:1000

相关文献

产品问答

相关产品

免责声明| 法律支持| 联系方式

市场:027-65023363   行政/人事:027-62439686   邮箱:marketing@brainvta.com  

销售总监:张经理  18995532642  华东区:陈经理 18013970337   华南区:王经理 13100653525   华中/西区:杨经理 18186518905   华北区:张经理 18893721749

地址:中国武汉东湖高新区光谷七路128号中科开物产业园1号楼

Copyright © 武汉枢密脑科学技术有限公司. All RIGHTS RESERVED.
鄂ICP备2021009124号 DIGITAL BY VTHINK